Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Genvec Inc (GNVC) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Genvec Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 934473.
Total stock buying since 2014: $237,106.
Total stock sales since 2014: $0.
Total stock option exercises since 2014: $305,850.
Insider Buying | Insider Sales | Option Exercises | ||||
---|---|---|---|---|---|---|
Year | Shares | Value | Shares | Value | Shares | Value |
2017 | 21,987 | $149,545 | 0 | $0 | 57,750 | $305,850 |
2016 | 10,000 | $5,000 | 0 | $0 | 0 | $0 |
2015 | 13,600 | $28,476 | 0 | $0 | 0 | $0 |
2014 | 24,140 | $54,085 | 0 | $0 | 0 | $0 |
Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
---|---|---|---|---|---|---|
year-month | Shares | Value | Shares | Value | Shares | Value |
2017-06 | 0 | $0 | 0 | $0 | 57,750 | $305,850 |
2017-03 | 21,987 | $149,545 | 0 | $0 | 0 | $0 |
2016-09 | 10,000 | $5,000 | 0 | $0 | 0 | $0 |
2015-12 | 5,000 | $10,000 | 0 | $0 | 0 | $0 |
2015-11 | 4,000 | $7,708 | 0 | $0 | 0 | $0 |
2015-08 | 4,600 | $10,768 | 0 | $0 | 0 | $0 |
2014-05 | 24,140 | $54,085 | 0 | $0 | 0 | $0 |
Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2017-06-16 | Lambert James Vincent (VP, Accounting & Finance) | Option Ex | 4,000 | 5.60 | 22,400 |
2017-06-16 | Mallette Quinterol J (Director) | Option Ex | 1,500 | 3.80 | 5,700 |
2017-06-16 | Brough Douglas E (Chief Scientific Officer) | Option Ex | 13,000 | 5.60 | 72,800 |
2017-06-16 | Loren Stefan (Director) | Option Ex | 1,500 | 3.80 | 5,700 |
2017-06-16 | Schneebaum Marc R (Director) | Option Ex | 1,500 | 3.80 | 5,700 |
2017-06-16 | Swirsky Douglas J (President and CEO) | Option Ex | 25,000 | 5.60 | 140,000 |
2017-06-16 | Richman Michael (Director) | Option Ex | 2,250 | 3.80 | 8,550 |
2017-06-16 | Butman Bryan T (Senior Vice President) | Option Ex | 6,000 | 5.60 | 33,600 |
2017-06-16 | Hockmeyer Wayne T (Director) | Option Ex | 1,500 | 3.80 | 5,700 |
2017-06-16 | Kelley Willam N (Director) | Option Ex | 1,500 | 3.80 | 5,700 |
2017-03-08 | Mmcap International Inc. Spc | Buy | 16,730 | 6.82 | 114,031 |
2017-03-07 | Mmcap International Inc. Spc | Buy | 1,100 | 6.68 | 7,345 |
2017-03-06 | Mmcap International Inc. Spc | Buy | 2,857 | 6.74 | 19,253 |
2017-03-03 | Mmcap International Inc. Spc | Buy | 1,300 | 6.86 | 8,916 |
2016-09-16 | Swirsky Douglas J (President & CEO) | Buy | 10,000 | .50 | 5,000 |
2015-12-14 | Swirsky Douglas J (President & CEO) | Buy | 5,000 | 2.00 | 10,000 |
2015-11-16 | Loren Stefan | Buy | 4,000 | 1.93 | 7,708 |
2015-08-11 | Brough Douglas E (Chief Scientific Officer) | Buy | 4,600 | 2.34 | 10,768 |
2014-05-27 | Nodelman Oleg | Buy | 9,040 | 2.39 | 21,623 |
2014-05-23 | Nodelman Oleg | Buy | 4,600 | 2.19 | 10,097 |
2014-05-22 | Nodelman Oleg | Buy | 10,500 | 2.13 | 22,365 |
Insider trading activities including stock purchases, stock sales, and option exercises of GNVC listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Genvec Inc (symbol GNVC, CIK number 934473) see the Securities and Exchange Commission (SEC) website.